Acute administration of l-tyrosine alters energetic metabolism of hippocampus and striatum of infant rats

Int J Dev Neurosci. 2013 Aug;31(5):303-7. doi: 10.1016/j.ijdevneu.2013.03.005. Epub 2013 Apr 16.

Abstract

Tyrosinemia type II is an inborn error of metabolism caused by mutations in the gene that encodes tyrosine aminotransferase, which leads to increased blood tyrosine levels. Considering that tyrosine levels are highly elevated in fluids of patients with tyrosinemia type II, and that previous studies demonstrated significant alterations in brain energy metabolism of young rats caused by l-tyrosine, the present study aimed to evaluate the effect of acute administration of l-tyrosine on the activities of citrate synthase, malate dehydrogenase, succinate dehydrogenase, and mitochondrial respiratory chain complexes I, II, II-III, and IV in posterior cortex, hippocampus, and striatum of infant rats. Wistar rats (10 days old) were killed 1h after a single intraperitoneal injection of tyrosine (500 mg/kg) or saline. The activities of energy metabolism enzymes were evaluated in brain of rats. Our results demonstrated that acute administration of l-tyrosine inhibited the activity of citrate synthase activity in striatum and increased the activities of malate dehydrogenase and succinate dehydrogenase in hippocampus. On the other hand, these enzymes were not affected in posterior cortex. The activities of complex I and complex II were inhibited by acute administration of l-tyrosine in striatum. On the other hand, the acute administration of l-tyrosine increased the activity of activity of complex II-III in hippocampus. Complex IV was not affected by acute administration of l-tyrosine in infant rats. Our results indicate an alteration in the energy metabolism in hippocampus and striatum of infant rats after acute administration of l-tyrosine. If the same effects occur in the brain of the patients, it is possible that energy metabolism impairment may be contribute to possible damage in memory and cognitive processes in patients with tyrosinemia type II.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Citrate (si)-Synthase / metabolism*
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Electron Transport Chain Complex Proteins / metabolism*
  • Energy Metabolism / drug effects
  • Energy Metabolism / physiology
  • Hippocampus / drug effects
  • Hippocampus / metabolism*
  • Malate Dehydrogenase / metabolism*
  • Male
  • Metabolic Clearance Rate / drug effects
  • Rats
  • Rats, Wistar
  • Succinate Dehydrogenase / metabolism*
  • Tissue Distribution / drug effects
  • Tyrosine / pharmacology*

Substances

  • Electron Transport Chain Complex Proteins
  • Tyrosine
  • Malate Dehydrogenase
  • Succinate Dehydrogenase
  • Citrate (si)-Synthase